Skip to main navigation Skip to search Skip to main content

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer

  • Alison T. Stopeck
  • , Karim Fizazi
  • , Jean Jacques Body
  • , Janet E. Brown
  • , Michael Carducci
  • , Ingo Diel
  • , Yasuhiro Fujiwara
  • , Miguel Martín
  • , Alexander Paterson
  • , Katia Tonkin
  • , Neal Shore
  • , Paul Sieber
  • , Frank Kueppers
  • , Lawrence Karsh
  • , Denise Yardley
  • , Huei Wang
  • , Tapan Maniar
  • , Jorge Arellano
  • , Ada Braun

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science